Back

Empagliflozin attenuates coronary atherosclerosis by promoting the differentiation of pericoronary adipose-derived stem cells

28 August 2026 (16:15 - 17:00)
Organised by: Logo
Congress Presentation Part of: Emerging pharmacologic strategies in coronary artery disease: anti-inflammatory, antithrombotic, and cardiometabolic approaches Pharmacotherapy ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Shaohua Shi

Nanjing (China)

5 More presentations in this session

Presentation thumbnail
Assessment of long-term safety of pro-angiogenic growth approaches in cardiovascular disease: A systematic review
Professor D. Bates (Nottingham, GB)
Abstract Slides
Presentation thumbnail
Leukotriene receptor antagonists and lower risk of major adverse cardiovascular events in patients with asthma
Assistant Professor J. Le Van (Montreal, CA)
Abstract Slides
Presentation thumbnail
A pharmacodynamic analysis of genotype-guided P2Y12-inhibitor monotherapy or dual antiplatelet therapy after PCI in patients with chronic coronary syndrome – the POPular STRATEGY study
Miss Q. Van De Pol (Nieuwegein, NL)
Abstract Slides
Presentation thumbnail
Anti-inflammatory effects of atorvastatin and colchicine combination in patients with acute or chronic coronary syndrome undergoing coronary angiography and/or PCI
Mr T. Trijitwatthanakoon (Bangkok, TH)
Abstract Slides
Presentation thumbnail
Colchicine serum levels in patients with chronic coronary syndrome
Miss J. Jannink (Utrecht, NL)
Abstract Slides

Access the full session

Session thumbnail
Emerging pharmacologic strategies in coronary artery disease: anti-inflammatory, antithrombotic, and cardiometabolic approaches

The Event

Event poster

ESC Congress 2026

28 August 2026 16:15 CET
You may be interested in
thumbnail
Congress Presentation
The presence of adverse atherosclerotic coronary plaque features is associated with diabetes
9 May 2021
thumbnail
Congress Presentation
Empagliflozin suppresses the differentiation/maturation of human epicardial preadipocytes and improves paracrine secretome profile
25 August 2023
thumbnail
Congress Presentation
Heart failure risk stratification and efficacy of dapagliflozin in patients with type 2 diabetes mellitus
31 August 2019
thumbnail
Congress Presentation
Epicardial adipose tissue volume and density is associated with cardiac dysfunction in asymptomatic people with type 2 diabetes
29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources